Providing market intelligence for more than 35 years

In The News

What is AT&T thinking with WatchTV?

“The unlimited data mobile wars have been going for awhile … as T-Mobile, AT&T and Verizon encourage people to (buy) the highest tier of mobile services,” said Brett Sappington, who studies both traditional and non-traditional pay TV providers at research outfit Parks Associates.

WatchTV, then, is just the latest incentive that AT&T can use to dangle in front of its (and its competitors’) customers to get them to pony up for its priciest wireless plans. The company has 160 million wireless subscribers in the U.S. and Canada, so getting those folks to spend more on their service promises billions in business. For context, in the first quarter, AT&T reported revenue of $38 billion, and more than $17 billion came from its biggest business: mobile.

From the article "What is AT&T thinking with WatchTV?" by Jennifer Van Grove.

Previously In The News

Latest U.S. Smartphone Market Numbers Show Apple In The Lead, But Samsung Is Catching Up

According to the latest U.S. smartphone market share numbers from Parks Associates, Apple is still well in the lead compared to competing manufacturers, holding a beefy 40% of the smartphone market. B...

Can mHealth Make Chronic Care Patients Care About Their Health?

According to the Parks Associates survey, 55 percent of Americans with at least one chronic condition aren’t speaking with their primary care physician any more than once every three months. What’s wo...

Most U.S. Wearable Owners Use Their Gadgets Daily: Study

The vast majority of fitness tracker and smartwatch owners in the United States use their wearables on a daily basis, according to the latest study from Parks Associates. Approximately 68-percent of f...

mHealth Looks to Solve the Diabetes Care Management Conundrum

Earlier this year, a report from digital health analyst Parks Associates found that 27 percent of people with a chronic condition want a mobile health device that tracks their health, but a significan...